The Wellcome Genome Campus is home to some of the world’s foremost institutes and organisations genomics and computational biology.  We bring together a diverse and exceptional scientific community in a culture and environment that fosters creativity and rewards bold, ambitious thinking.  We are committed to delivering life-changing science with the reach, scale and imagination to solve some of humanity’s greatest challenges.

The Campus is managed and operated by Genome Research Ltd (GRL), a Charity registered in England. GRL was established in 1992 and is a wholly owned subsidiary of the Wellcome Trust. In 2012, the Wellcome Trust Board of Governors agreed to place all activities on the Wellcome Genome Campus, including the Sanger Institute, under the auspices of GRL in order to facilitate the development of a long term and coherent strategy for the Campus and all activities on it.

The ambition of GRL over the next 20 years is to strengthen its well-established scientific foundations and to build on them, such that the Wellcome Genome Campus becomes an international centre for scientific, business, cultural and educational activities emanating from Genomes and BioData. To achieve this vision GRL’s Mission is to:

  • Advance understanding of biology using genome sequences and biodata.
  • Apply genome science for human health and other societal benefits.
  • Foster discussion of the scientific, medical and wider implications of genomes.

The GRL Board of Directors can be found here.

 

Future growth plans for the Wellcome Genome Campus

Future plans

The Wellcome Genome Campus has plans for further development and expansion of its facilities and footprint. Once complete, the Campus will be firmly established as an already international centre for scientific, business, cultural and educational activities flowing from genomes and computational biology.

Know more